The DOI matches its Crossref record; 166 of the 166 references it cites were found in a registry or an index.
Matching chelators to radiometals for radiopharmaceuticals
Abstract
Radiometals comprise many useful radioactive isotopes of various metallic elements. When properly harnessed, these have valuable emission properties that can be used for diagnostic imaging techniques, such as single photon emission computed tomography (SPECT, e.g.(67)Ga, (99m)Tc, (111)In, (177)Lu) and positron emission tomography (PET, e.g.(68)Ga, (64)Cu, (44)Sc, (86)Y, (89)Zr), as well as therapeutic applications (e.g.(47)Sc, (114m)In, (177)Lu, (90)Y, (212/213)Bi, (212)Pb, (225)Ac, (186/188)Re). A fundamental critical component of a radiometal-based radiopharmaceutical is the chelator, the ligand system that binds the radiometal ion in a tight stable coordination complex so that it can be properly directed to a desirable molecular target in vivo. This article is a guide for selecting the optimal match between chelator and radiometal for use in these systems. The article briefly introduces a selection of relevant and high impact radiometals, and their potential utility to the fields of radiochemistry, nuclear medicine, and molecular imaging. A description of radiometal-based radiopharmaceuticals is provided, and several key design considerations are discussed. The experimental methods by which chelators are assessed for their suitability with a variety of radiometal ions is explained, and a large selection of the most common and most promising chelators are evaluated and discussed for their potential use with a variety of radiometals. Comprehensive tables have been assembled to provide a convenient and accessible overview of the field of radiometal chelating agents.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shannon, R. D. (1976) · Acta Crystallographica Section A · doi:10.1107/s0567739476001551 · Cited by 66,145
Critical Stability Constants: First Supplement
Martell, A. E., & Smith, R. M. (1982) · Springer eBooks · doi:10.1007/978-1-4615-6761-5 · Cited by 6,008
Firestone, R. B., & Shirley, V. S. (1967) · Medical Entomology and Zoology · Cited by 3,557
Rae, T. D., Schmidt, P. J., Pufahl, R. A., Culotta, V. C., & V. O'Halloran, T. (1999) · Science · doi:10.1126/science.284.5415.805 · Cited by 1,629
Theranostics: Combining Imaging and Therapy
Kelkar, S. S., & Reineke, T. M. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200151q · Cited by 1,385
Gabriel, M., Decristoforo, C., Kendler, D., Dobrozemsky, G., Heute, D., Uprimny, C., Kovacs, P., Von Guggenberg, E., Bale, R., & Virgolini, I. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.035667 · Cited by 1,010
Wadas, T. J., Wong, E. H., Weisman, G. R., & Anderson, C. J. (2010) · Chemical Reviews · doi:10.1021/cr900325h · Cited by 924
Smith, R. M., & Martell, A. E. (1989) · Springer eBooks · doi:10.1007/978-1-4615-6764-6 · Cited by 691
Potential Technetium Small Molecule Radiopharmaceuticals
Jurisson, S. S., & Lydon, J. D. (1999) · Chemical Reviews · doi:10.1021/cr980435t · Cited by 592
Hofmann, M., Maecke, H., Börner, A., Weckesser, E., Schöffski, P., Oei, M., Schumacher, J., Henze, M., Heppeler, A., Meyer, G., et al. (2001) · European Journal of Nuclear Medicine · doi:10.1007/s002590100639 · Cited by 544
Boswell, C. A., Sun, X., Niu, W., Weisman, G. R., Wong, E. H., Rheingold, A. L., & Anderson, C. J. (2004) · Journal of Medicinal Chemistry · doi:10.1021/jm030383m · Cited by 483
Radiometal-Labeled Agents (Non-Technetium) for Diagnostic Imaging
Anderson, C. J., & Welch, M. J. (1999) · Chemical Reviews · doi:10.1021/cr980451q · Cited by 455
PET imaging with 89Zr: From radiochemistry to the clinic
Deri, M. A., Zeglis, B. M., Francesconi, L. C., & Lewis, J. S. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2012.08.004 · Cited by 423
Liu, S. (2008) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2008.04.006 · Cited by 420
89Zr-DFO-J591 for ImmunoPET of Prostate-Specific Membrane Antigen Expression In Vivo
Holland, J. P., Divilov, V., Bander, N. H., Smith-Jones, P. M., Larson, S. M., & Lewis, J. S. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.076174 · Cited by 418
Standardized methods for the production of high specific-activity zirconium-89
Holland, J. P., Sheh, Y., & Lewis, J. S. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2009.05.007 · Cited by 408
Copper radionuclides and radiopharmaceuticals in nuclear medicine
Blower, P. J., Lewis, J. S., & Zweit, J. (1996) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(96)00130-8 · Cited by 406
Radiometals for Combined Imaging and Therapy
Cutler, C. S., Hennkens, H. M., Sisay, N., Huclier-Markai, S., & Jurisson, S. S. (2013) · Chemical Reviews · doi:10.1021/cr3003104 · Cited by 395
Haubner, R., Wester, H. J., Burkhart, F., Senekowitsch–Schmidtke, R., Weber, W., Goodman, S. L., Kessler, H., & Schwaiger, M. (2001) · PubMed · Cited by 381
Transferrin as a Metal Ion Mediator
Sun, H., Li, H., & Sadler, P. J. (1999) · Chemical Reviews · doi:10.1021/cr980430w · Cited by 377
Bifunctional Chelators for Therapeutic Lanthanide Radiopharmaceuticals
Liu, S., & Edwards, D. S. (2001) · Bioconjugate Chemistry · doi:10.1021/bc000070v · Cited by 351
Development and Characterization of Clinical-Grade 89Zr-Trastuzumab for HER2/neu ImmunoPET Imaging
Dijkers, E. C. F., Kosterink, J. G. W., Rademaker, A. P., Perk, L. R., van Dongen, G. A. M. S., Bart, J., de Jong, J. R., de Vries, E. G. E., & Lub-de Hooge, M. N. (2009) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.060392 · Cited by 334
Thermodynamic binding constants for gallium transferrin
Harris, W. R., & Pecoraro, V. L. (1983) · Biochemistry · doi:10.1021/bi00271a010 · Cited by 330
Immuno-PET: A Navigator in Monoclonal Antibody Development and Applications
van Dongen, G. A. M. S., Visser, G. W. M., Lub-de Hooge, M. N., de Vries, E. G., & Perk, L. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-12-1379 · Cited by 330
Bakker, W. H., Albert, R., Bruns, C., Breeman, W. A. P., Hofland, L. J., Marbach, P., Pless, J., Pralet, D., Stolz, B., Koper, J. W., et al. (1991) · Life Sciences · doi:10.1016/0024-3205(91)90052-d · Cited by 328
In Vivo VEGF Imaging with Radiolabeled Bevacizumab in a Human Ovarian Tumor Xenograft
Nagengast, W. B., de Vries, E. G., Hospers, G. A., Mulder, N. H., de Jong, J. R., Hollema, H., Brouwers, A. H., van Dongen, G. A., Perk, L. R., & Lub-de Hooge, M. N. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.041301 · Cited by 313
In Vivo Transchelation of Copper-64 from TETA-Octreotide to Superoxide Dismutase in Rat Liver
Bass, L. A., Wang, M., Welch, M. J., & Anderson, C. J. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990167l · Cited by 311
Bartholomä, M. D., Louie, A. S., Valliant, J. F., & Zubieta, J. (2010) · Chemical Reviews · doi:10.1021/cr1000755 · Cited by 298
Copper Chelation Chemistry and its Role in Copper Radiopharmaceuticals
Wadas, T., Wong, E., Weisman, G., & Anderson, C. (2007) · Current Pharmaceutical Design · doi:10.2174/138161207779313768 · Cited by 296
Evers, A., Hancock, R. D., Martell, A. E., & Motekaitis, R. J. (1989) · Inorganic Chemistry · doi:10.1021/ic00310a035 · Cited by 290
Brechbiel, M. W., Gansow, O. A., Atcher, R. W., Schlom, J., Esteban, J., Simpson, D., & Colcher, D. (1986) · Inorganic Chemistry · doi:10.1021/ic00236a024 · Cited by 289
Baum, R. P., & Kulkarni, H. R. (2012) · Theranostics · doi:10.7150/thno.3645 · Cited by 283
Kumar, K., Chang, C. A., Francesconi, L. C., Dischino, D. D., Malley, M. F., Gougoutas, J. Z., & Tweedle, M. F. (1994) · Inorganic Chemistry · doi:10.1021/ic00094a021 · Cited by 280
64Cu-TETA-octreotide as a PET imaging agent for patients with neuroendocrine tumors.
Anderson, C. J., Dehdashti, F., Cutler, P. D., Schwarz, S. W., Laforest, R. A., Bass, L. A., Lewis, J. S., & Mccarthy, D. W. (2001) · PubMed · Cited by 273
Fani, M., Del Pozzo, L., Abiraj, K., Mansi, R., Tamma, M. L., Cescato, R., Waser, B., Weber, W. A., Reubi, J. C., & Maecke, H. R. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087999 · Cited by 262
Smith, R. M., & Martell, A. E. (1987) · The Science of The Total Environment · doi:10.1016/0048-9697(87)90127-6 · Cited by 256
Tumour targeting with radiometals for diagnosis and therapy
Ramogida, C. F., & Orvig, C. (2013) · Chemical Communications · doi:10.1039/c3cc41554f · Cited by 255
Self-citationDevelopment of radioimmunotherapeutic and diagnostic antibodies: an inside-out view
Boswell, C. A., & Brechbiel, M. W. (2007) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2007.04.001 · Cited by 241
Clarke, E. T., & Martell, A. E. (1991) · Inorganica Chimica Acta · doi:10.1016/s0020-1693(00)80229-7 · Cited by 229
Design and synthesis of 225Ac radioimmunopharmaceuticals.
McDevitt, M. R., Ma, D., Simon, J., Frank, R. K., & Scheinberg, D. A. (2002) · Applied Radiation and Isotopes · doi:10.1016/s0969-8043(02)00167-7 · Cited by 225
Bioorthogonal Reaction Pairs Enable Simultaneous, Selective, Multi‐Target Imaging
Karver, M. R., Weissleder, R., & Hilderbrand, S. A. (2012) · Angewandte Chemie International Edition · doi:10.1002/anie.201104389 · Cited by 220
Cooper, M. S., Ma, M. T., Sunassee, K., Shaw, K. P., Williams, J. D., Paul, R. L., Donnelly, P. S., & Blower, P. J. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300037w · Cited by 217
Eisenwiener, K.-P., Prata, M. I. M., Buschmann, I., Zhang, H.-W., Santos, A. C., Wenger, S., Reubi, J. C., & Mäcke, H. R. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010074f · Cited by 213
Radiopharmaceutical chemistry for positron emission tomography
Li, Z., & Conti, P. S. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.09.007 · Cited by 212
Perk, L. R., Visser, G. W. M., Vosjan, M. J. W. D., van Walsum, M., Tijink, B. M., Leemans, C. R., & van Dongen, G. A. M. S. (2005) · PubMed · Cited by 205
Cordier, D., Forrer, F., Bruchertseifer, F., Morgenstern, A., Apostolidis, C., Good, S., Müller-Brand, J., Mäcke, H., Reubi, J. C., & Merlo, A. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-010-1385-5 · Cited by 204
Breeman, W. A. P., de Blois, E., Sze Chan, H., Konijnenberg, M., Kwekkeboom, D. J., & Krenning, E. P. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.02.001 · Cited by 203
Zeglis, B. M., & Lewis, J. S. (2011) · Dalton Transactions · doi:10.1039/c0dt01595d · Cited by 198
Preclinical characterisation of 111In‐DTPA‐trastuzumab
Lub‐de Hooge, M. N., Kosterink, J. G. W., Perik, P. J., Nijnuis, H., Tran, L., Bart, J., Suurmeijer, A. J. H., de Jong, S., Jager, P. L., & de Vries, E. G. E. (2004) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0705915 · Cited by 176
Gallium(III) Complexes of DOTA and DOTA−Monoamide: Kinetic and Thermodynamic Studies
Kubíček, V., Havlíčková, J., Kotek, J., Tircsó, G., Hermann, P., Tóth, É., & Lukeš, I. (2010) · Inorganic Chemistry · doi:10.1021/ic101378s · Cited by 176
Nikula, T. K., McDevitt, M. R., Finn, R. D., Wu, C., Kozak, R. W., Garmestani, K., Brechbiel, M. W., Curcio, M. J., Pippin, C. G., Tiffany-Jones, L., et al. (1999) · PubMed · Cited by 176
Heneweer, C., Holland, J. P., Divilov, V., Carlin, S., & Lewis, J. S. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.083998 · Cited by 172
Unconventional Nuclides for Radiopharmaceuticals
Holland, J. P., Williamson, M. J., & Lewis, J. S. (2010) · Molecular Imaging · doi:10.2310/7290.2010.00008 · Cited by 167
Zeglis, B. M., Mohindra, P., Weissmann, G. I., Divilov, V., Hilderbrand, S. A., Weissleder, R., & Lewis, J. S. (2011) · Bioconjugate Chemistry · doi:10.1021/bc200288d · Cited by 162
Chappell, L. L., Dadachova, E., Milenic, D. E., Garmestani, K., Wu, C., & Brechbiel, M. W. (2000) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(99)00086-4 · Cited by 159
Panizzi, P., Nahrendorf, M., Figueiredo, J.-L., Panizzi, J., Marinelli, B., Iwamoto, Y., Keliher, E., Maddur, A. A., Waterman, P., Kroh, H. K., et al. (2011) · Nature Medicine · doi:10.1038/nm.2423 · Cited by 159
Kimura, R. H., Cheng, Z., Gambhir, S. S., & Cochran, J. R. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-2495 · Cited by 158
Hong, S., Hobbs, R. F., Vajravelu, R. K., Huso, D. L., Esaias, C. E., Apostolidis, C., Morgenstern, A., & Sgouros, G. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1828 · Cited by 158
Dumont, R. A., Deininger, F., Haubner, R., Maëcke, H. R., Weber, W., & Fani, M. (2011) · Journal of Nuclear Medicine · doi:10.2967/jnumed.111.087700 · Cited by 157
Harris, W. R., & Messori, L. (2002) · Coordination Chemistry Reviews · doi:10.1016/s0010-8545(02)00037-1 · Cited by 145
Bifunctional chelates for metal nuclides.
Brechbiel, M. W. (2008) · PubMed · Cited by 143
Majkowska‐Pilip, A., & Bilewicz, A. (2010) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2010.11.003 · Cited by 140
Wild, D., Frischknecht, M., Zhang, H., Morgenstern, A., Bruchertseifer, F., Boisclair, J., Provencher-Bolliger, A., Reubi, J., & Maëcke, H. R. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-1186 · Cited by 137
Camera, L., Kinuya, S., Garmestani, K., Wu, C., Brechbiel, M. W., Pai, L. H., McMurry, T. J., Gansow, O. A., Pastan, I. H., & Paik, C. H. (1994) · PubMed · Cited by 137
Backbone-substituted DTPA ligands for yttrium-90 radioimmunotherapy
Brechbiel, M. W., & Gansow, O. A. (1991) · Bioconjugate Chemistry · doi:10.1021/bc00009a008 · Cited by 135
Hassfjell, S. P., & Brechbiel, M. W. (2001) · Chemical Reviews · doi:10.1021/cr000118y · Cited by 135
Maumela, H., Hancock, R. D., Carlton, L., Reibenspies, J. H., & Wainwright, K. P. (1995) · Journal of the American Chemical Society · doi:10.1021/ja00130a008 · Cited by 131
Improved in vivo stability and tumor targeting of bismuth-labeled antibody.
Ruegg, C. L., Anderson-Berg, W. T., Brechbiel, M. W., Mirzadeh, S., Gansow, O. A., & Strand, M. (1990) · PubMed · Cited by 130
Improved in Vivo Stability of Actinium-225 Macrocyclic Complexes
Deal, K. A., Davis, I. A., Mirzadeh, S., Kennel, S. J., & Brechbiel, M. W. (1999) · Journal of Medicinal Chemistry · doi:10.1021/jm990141f · Cited by 130
Imaging of Melanoma Using 64Cu− and 86Y−DOTA−ReCCMSH(Arg11), a Cyclized Peptide Analogue of α-MSH
Mcquade, P. S., Miao, Y., Yoo, J., Quinn, T. P., Welch, M. J., & Lewis, J. S. (2005) · Journal of Medicinal Chemistry · doi:10.1021/jm0490282 · Cited by 129
Holland, J. P., Caldas-Lopes, E., Divilov, V., Longo, V. A., Taldone, T., Zatorska, D., Chiosis, G., & Lewis, J. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0008859 · Cited by 129
Bartholomä, M. D. (2012) · Inorganica Chimica Acta · doi:10.1016/j.ica.2012.01.061 · Cited by 129
Schwartz, J., Jaggi, J. S., O’Donoghue, J. A., Ruan, S., McDevitt, M. R., Larson, S. M., Scheinberg, D. A., & Humm, J. L. (2011) · Physics in Medicine and Biology · doi:10.1088/0031-9155/56/3/012 · Cited by 128
The Growing Impact of Bioorthogonal Click Chemistry on the Development of Radiopharmaceuticals
Zeng, D., Zeglis, B. M., Lewis, J. S., et al. (2013) · Journal of Nuclear Medicine · doi:10.2967/jnumed.112.115550 · Cited by 126
Dimitrakopoulou‐Strauss, A., Hohenberger, P., Haberkorn, U., Mäcke, H. R., Eisenhut, M., & Strauss, L. G. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.106.038091 · Cited by 124
Velikyan, I., Sundberg, Å. L., Lindhe, Ö., Höglund, A. U., Eriksson, O., Werner, E., Carlsson, J., Bergström, M., Långström, B., & Максимилианович, Т. В. (2005) · PubMed · Cited by 121
Miederer, M., McDevitt, M. R., Sgouros, G., Kramer, K., Cheung, N. V., & Scheinberg, D. A. (2004) · PubMed · Cited by 119
Convenient synthesis of bifunctional tetraaza macrocycles
McMurry, T. J., Brechbiel, M. W., Kumar, K., & Gansow, O. A. (1992) · Bioconjugate Chemistry · doi:10.1021/bc00014a004 · Cited by 119
Šimeček, J., Schulz, M., Notni, J., Plutnar, J., Kubíček, V., Havlíčková, J., & Hermann, P. (2011) · Inorganic Chemistry · doi:10.1021/ic202103v · Cited by 117
Ferdani, R., Stigers, D. J., Fiamengo, A. L., Wei, L., Li, B. T. Y., Golen, J. A., Rheingold, A. L., Weisman, G. R., Wong, E. H., & Anderson, C. J. (2011) · Dalton Transactions · doi:10.1039/c1dt11743b · Cited by 116
H4octapa: An Acyclic Chelator for 111In Radiopharmaceuticals
Price, E. W., Cawthray, J. F., Bailey, G. A., Ferreira, C. L., Boros, E., Adam, M. J., & Orvig, C. (2012) · Journal of the American Chemical Society · doi:10.1021/ja3024725 · Cited by 116
Self-citationBrechbiel, M. W., & Gansow, O. A. (1992) · Journal of the Chemical Society Perkin Transactions 1 · doi:10.1039/p19920001173 · Cited by 115
Bartolo, N. M. D., Sargeson, A. M., & Smith, S. V. (2006) · Organic & Biomolecular Chemistry · doi:10.1039/b605615f · Cited by 113
Reiner, T., Lacy, J. N., Keliher, E. J., Yang, K. S., Ullal, A. V., Köhler, R. H., Vinegoni, C., & Weissleder, R. (2012) · Neoplasia · doi:10.1593/neo.12414 · Cited by 112
Preparation of alpha-emitting 213Bi-labeled antibody constructs for clinical use.
McDevitt, M. R., Finn, R. D., Ma, D., Larson, S. M., & Scheinberg, D. A. (1999) · PubMed · Cited by 112
Towards translation of 212Pb as a clinical therapeutic; getting the lead in!
Yong, K. J., & Brechbiel, M. W. (2011) · Dalton Transactions · doi:10.1039/c0dt01387k · Cited by 111
Milenic, D. E., Garmestani, K., Chappell, L. L., Dadachova, E., Yordanov, A. T., Ma, D., Schlom, J., & Brechbiel, M. W. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(02)00294-9 · Cited by 110
Wu, C., Kobayashi, H., Sun, B., Yoo, T. M., Paik, C. H., Gansow, O. A., Carrasquillo, J. A., Pastan, I. H., & Brechbiel, M. W. (1997) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(97)00130-2 · Cited by 109
Ballangrud, Å., Yang, W.-H., Palm, S., Enmon, R. M., Borchardt, P. E., Pellegrini, V., McDevitt, M. R., Scheinberg, D. A., & Sgouros, G. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0800 · Cited by 106
Norenberg, J. P., Krenning, B. J., Konings, I. R. H. M., Kusewitt, D. F., Nayak, T. K., Anderson, T. L., de Jong, M., Garmestani, K., Brechbiel, M. W., & Kvols, L. K. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1264 · Cited by 105
The chemistry of gallium and indium as related to radiopharmaceutical production
Moerlein, S. M., & Welch, M. J. (1981) · International Journal of Nuclear Medicine and Biology · doi:10.1016/0047-0740(81)90034-6 · Cited by 103
Reiner, T., Keliher, E. J., Earley, S., et al. (2011) · Angewandte Chemie International Edition · doi:10.1002/anie.201006579 · Cited by 102
Evaluation of Bifunctional Chelates for the Development of Gallium-Based Radiopharmaceuticals
Ferreira, C. L., Lamsa, E., Woods, M., Duan, Y., Fernando, P., Bensimon, C., Kordos, M., Guenther, K. J., Jurek, P. E., & Kiefer, G. E. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900443a · Cited by 100
Sun, Y., Anderson, C. J., Pajeau, T. S., Reichert, D. E. C., Hancock, R. D., Motekaitis, R. J., Martell, A. E., & Welch, M. J. (1996) · Journal of Medicinal Chemistry · doi:10.1021/jm9505977 · Cited by 99
‘Click labelling’ in PET radiochemistry
Glaser, M., & Robins, E. G. (2009) · Journal of Labelled Compounds and Radiopharmaceuticals · doi:10.1002/jlcr.1656 · Cited by 99
The Next Generation of Positron Emission Tomography Radiopharmaceuticals in Oncology
Rice, S. L., Roney, C. A., Daumar, P., & Lewis, J. S. (2011) · Seminars in Nuclear Medicine · doi:10.1053/j.semnuclmed.2011.02.002 · Cited by 96
Wei, L., Ye, Y., Wadas, T. J., Lewis, J. S., Welch, M. J., Achilefu, S. A., & Anderson, C. J. (2009) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2008.12.008 · Cited by 95
Iodine-124: A Promising Positron Emitter for Organic PET Chemistry
Koehler, L., Gagnon, K., McQuarrie, S. A., & Wuest, F. R. (2010) · Molecules · doi:10.3390/molecules15042686 · Cited by 95
Zirconium-labeled monoclonal antibodies and their distribution in tumor-bearing nude mice.
Meijs, W. E., Haisma, H. J., Klok, R. P., et al. (1997) · PubMed · Cited by 92
Carrasquillo, J. A., White, J. D., Paik, C. H., et al. (1999) · PubMed · Cited by 87
Radioimmunotherapy targeting of HER2/neu oncoprotein on ovarian tumor using lead-212-DOTA-AE1.
Horak, E. M., Hartmann, F., Garmestani, K., Wu, C., Brechbiel, M. W., Gansow, O. A., Landolfi, N. F., & Waldmann, T. A. (1997) · PubMed · Cited by 86
Waldron, B. P., Parker, D., Burchardt, C., Yufit, D. S., Zimny, M., & Roesch, F. (2012) · Chemical Communications · doi:10.1039/c2cc37544c · Cited by 86
Lee, F.-T., Mountain, A. J., Kelly, M. P., Hall, C. M., Rigopoulos, A., Johns, T. G., Smyth, F. E., Brechbiel, M. W., Nice, E. C., Burgess, A. W., et al. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-1004-0019 · Cited by 85
Dosimetry of yttrium-labelled radiopharmaceuticals for internal therapy: 86Y or 90Y imaging?
Walrand, S., Flux, G., Konijnenberg, M., Valkema, R., Krenning, E. P., Lhommel, R., Pauwels, S. A., & Jamar, F. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1771-7 · Cited by 84
André, J. P., Maëcke, H. R., André, J. P., Zehnder, M., Macko, L., & Akyel, K. G. (1998) · Chemical Communications · doi:10.1039/a801294f · Cited by 84
Chappell, L. L., Deal, K. A., Dadachova, E., & Brechbiel, M. W. (2000) · Bioconjugate Chemistry · doi:10.1021/bc990153f · Cited by 82
Positron emission tomography imaging of CD105 expression with 89Zr-Df-TRC105
Hong, H., Severin, G. W., Yang, Y., Engle, J. W., Zhang⋆, Y., Barnhart, T. E., Liu, G., Leigh, B. R., Nickles, R. J., & Cai, W. (2011) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-011-1930-x · Cited by 82
Evaluation of 225 Ac for Vascular Targeted Radioimmunotherapy of Lung Tumors
Kennel, S. J., Chappell, L. L., Dadachova, K., Brechbiel, M. W., Lankford, T. K., Davis, I. A., Stabin, M. G., & Mirzadeh, S. (2000) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497800414329 · Cited by 82
DOTAGA–Anhydride: A Valuable Building Block for the Preparation of DOTA‐Like Chelating Agents
Bernhard, C., Moreau, M., Lhenry, D., Goze, C., Boschetti, F., Rousselin, Y., Brunotte, F., & Denat, F. (2012) · Chemistry - A European Journal · doi:10.1002/chem.201200132 · Cited by 82
Samarium-153 and Lutetium-177 Chelation Properties of Selected Macrocyclic and Acyclic Ligands
Stimmel, J. B., & Kull, F. C. (1998) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(97)00151-0 · Cited by 79
Šimeček, J., Hermann, P., Wester, H., & Notni, J. (2012) · ChemMedChem · doi:10.1002/cmdc.201200471 · Cited by 78
PET imaging of HER1-expressing xenografts in mice with 86Y-CHX-A″-DTPA-cetuximab
Nayak, T. K., Regino, C. A. S., Wong, K. J., Milenic, D. E., Garmestani, K., Baidoo, K. E., Szajek, L. P., & Brechbiel, M. W. (2010) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1370-z · Cited by 75
Kang, C. S., Sun, X. Y., Jia, F., Song, H. A., Chen, Y., Lewis, M. R., & Chong, H. (2012) · Bioconjugate Chemistry · doi:10.1021/bc200696b · Cited by 74
Methodology for labeling proteins and peptides with lead-212 (212Pb)
Baidoo, K. E., Milenic, D. E., & Brechbiel, M. W. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.01.010 · Cited by 73
Reproducibility of quantitative (R)-[11C]verapamil studies
van Assema, D. M. E., Lubberink, M., Boellaard, R., Schuit, R. C., Windhorst, A. D., Scheltens, P., van Berckel, B. N. M., & Lammertsma, A. A. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-1 · Cited by 71
PET imaging of tumor angiogenesis in mice with VEGF‐A–targeted 86Y‐CHX‐A″‐DTPA‐bevacizumab
Nayak, T. K., Garmestani, K., Baidoo, K. E., Milenic, D. E., & Brechbiel, M. W. (2010) · International Journal of Cancer · doi:10.1002/ijc.25409 · Cited by 71
Gordon, L. I., Witzig, T. E., Wiseman, G., Flinn, I. W., Spies, S., Silverman, D. H. S., Emmanuolides, C., Cripe, L. D., Saleh, M. N., Czuczman, M. S., et al. (2002) · Seminars in Oncology · doi:10.1053/sonc.2002.30148 · Cited by 70
Stability of metal ion complexes of N,N′-bis(2-hydroxybenzyl)ethylenediamine-N,N′-diacetic acid
Ma, R., Motekaitis, R. J., & Martell, A. E. (1994) · Inorganica Chimica Acta · doi:10.1016/0020-1693(94)04012-5 · Cited by 68
Optimized conditions for chelation of yttrium-90-DOTA immunoconjugates.
Kukis, D. L., DeNardo, S. J., DeNardo, G. L., et al. (1998) · PubMed · Cited by 66
Zn(ii), Cd(ii) and Pb(ii) complexation with pyridinecarboxylate containing ligands
Ferreirós‐Martínez, R., Esteban‐Gómez, D., Platas‐Iglesias, C., Blas, A. D., & Rodríguez-Blas, T. (2008) · Dalton Transactions · doi:10.1039/b808631a · Cited by 66
Hausner, S. H., Kukis, D. L., Gagnon, M.-H., Stanecki, C. E., Ferdani, R., Marshall, J. F., Anderson, C. J., & Sutcliffe-Goulden, J. (2009) · Molecular Imaging · doi:10.2310/7290.2009.00015 · Cited by 65
Brechbiel, M. W., Gansow, O. A., Pippin, C. G., Rogers, R. D., & Planalp, R. P. (1996) · Inorganic Chemistry · doi:10.1021/ic951326p · Cited by 64
68 Ga Small Peptide Imaging: Comparison of NOTA and PCTA
Ferreira, C. L., Yapp, D. T. T., Mandel, D., Gill, R. K., Boros, E., Wong, M. Q., Jurek, P. E., & Kiefer, G. E. (2012) · Bioconjugate Chemistry · doi:10.1021/bc300348d · Cited by 62
Motekaitis, R. J., Martell, A. E., Koch, S. A., et al. (1998) · Inorganic Chemistry · doi:10.1021/ic980227j · Cited by 62
Chappell, L. L., Ma, D., Milenic, D. E., Garmestani, K., Venditto, V. J., Beitzel, M., & Brechbiel, M. W. (2003) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(03)00033-7 · Cited by 60
Efficient Bifunctional Decadentate Ligand 3p-C-DEPA for Targeted α-Radioimmunotherapy Applications
Song, H. A., Kang, C. S., Baidoo, K. E., Milenic, D. E., Chen, Y., Dai, A., Brechbiel, M. W., & Chong, H. (2011) · Bioconjugate Chemistry · doi:10.1021/bc100586y · Cited by 60
Nayak, T. K., Garmestani, K., Baidoo, K. E., Milenic, D. E., & Brechbiel, M. W. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.109.071290 · Cited by 59
Liu, S., Pietryka, J., Ellars, C. E., & Edwards, D. S. (2002) · Bioconjugate Chemistry · doi:10.1021/bc010134h · Cited by 58
Novel chelating agents for potential clinical applications of copper
Ma, D., Lu, F., Overstreet, T., Milenic, D. E., & Brechbiel, M. W. (2002) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(01)00287-6 · Cited by 57
Evaluation of 111In-Labeled Cyclic RGD Peptides: Tetrameric not Tetravalent
Chakraborty, S., Shi, J., Kim, Y., Zhou, Y., Jia, B., Wang, F., & Liu, S. (2010) · Bioconjugate Chemistry · doi:10.1021/bc900555q · Cited by 56
Kang, C. S., Song, H. A., Milenic, D. E., Baidoo, K. E., Brechbiel, M. W., & Chong, H. (2013) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2013.01.012 · Cited by 56
Milenic, D. E., Roselli, M., Mirzadeh, S., Pippin, C. G., Gansow, O. A., Colcher, D. M., Brechbiel, M. W., & Schlom, J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/108497801300189227 · Cited by 56
Stability constants of metal complexes of macrocyclic ligands with pendant donor groups
Martell, A. E., Motekaitis, R. J., Clarke, E. T., Delgado, R., Sun, Y., & Ma, R. (1996) · Supramolecular chemistry · doi:10.1080/10610279608032555 · Cited by 55
Nayak, T. K., Garmestani, K., Milenic, D. E., Baidoo, K. E., & Brechbiel, M. W. (2011) · PLoS ONE · doi:10.1371/journal.pone.0018198 · Cited by 54
Li, Y., Martell, A. E., Hancock, R. D., Reibenspies, J. H., Anderson, C. J., & Welch, M. J. (1996) · Inorganic Chemistry · doi:10.1021/ic941330l · Cited by 53
Efficient synthesis and evaluation of bimodal ligand NETA
Chong, H., Song, H. A., Birch, N. W., Le, T., Lim, S., & Ma, X. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.03.084 · Cited by 49
Clifford, T., Boswell, C. A., Biddlecombe, G. B., Lewis, J. S., & Brechbiel, M. W. (2006) · Journal of Medicinal Chemistry · doi:10.1021/jm060317v · Cited by 49
The use of 212Pb-labeled monoclonal antibody in the treatment of murine erythroleukemia
Ruble, G., Wu, C., Squire, R. A., Gansow, O. A., & Strand, M. (1996) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/0360-3016(95)02119-1 · Cited by 49
Novel Bimodal Bifunctional Ligands for Radioimmunotherapy and Targeted MRI
Chong, H., Song, H. A., Ma, X., Milenic, D. E., Brady, E. D., Lim, S., Lee, H., Baidoo, K. E., Cheng, D., & Brechbiel, M. W. (2008) · Bioconjugate Chemistry · doi:10.1021/bc800050x · Cited by 48
Camera, L., Kinuya, S., Garmestani, K., Brechbiel, M. W., Wu, C., Pai, L. H., McMurry, T. J., Gansow, O. A., Pastan, I., Paik, C. H., et al. (1994) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/bf00285586 · Cited by 46
Selectivity of Potentially Hexadentate Amine Phenols for Ga3+ and In3+ in Aqueous Solution,
Wong, E., Caravan, P. D., Liu, S., Rettig, S. J., & Orvig, C. (1996) · Inorganic Chemistry · doi:10.1021/ic951019j · Cited by 46
Self-citationLiu, S., He, Z., Hsieh, W., & Fanwick, P. E. (2003) · Inorganic Chemistry · doi:10.1021/ic0349914 · Cited by 45
Lewis, M. R., Boswell, C. A., Laforest, R. A., Buettner, T. L., Ye, D., Connett, J. M., & Anderson, C. J. (2001) · Cancer Biotherapy and Radiopharmaceuticals · doi:10.1089/10849780152752083 · Cited by 45
Ma, R., Welch, M. J., Reibenspies, J. H., & Martell, A. E. (1995) · Inorganica Chimica Acta · doi:10.1016/0020-1693(95)04617-i · Cited by 43
In vitro and in vivo evaluation of novel ligands for radioimmunotherapy
Chong, H., Milenic, D. E., Garmestani, K., Brady, E. D., Arora, H., Pfiester, C. M., & Brechbiel, M. W. (2006) · Nuclear Medicine and Biology · doi:10.1016/j.nucmedbio.2006.03.004 · Cited by 42
Chappell, L. L., Rogers, B. E., Khazaeli, M. B., Mayo, M. S., Buchsbaum, D. J., & Brechbiel, M. W. (1999) · Bioorganic & Medicinal Chemistry · doi:10.1016/s0968-0896(99)00171-6 · Cited by 40
Search of ligands suitable for 212Pb/212Bi in vivo generators
Bartoś, B., Łyczko, K., Kasperek, A., Krajewski, S., & Bilewicz, A. (2012) · Journal of Radioanalytical and Nuclear Chemistry · doi:10.1007/s10967-012-2238-4 · Cited by 37
Ferreirós‐Martínez, R., Esteban‐Gómez, D., Blas, A. D., Platas‐Iglesias, C., & Rodríguez-Blas, T. (2009) · Inorganic Chemistry · doi:10.1021/ic901883h · Cited by 37
Ferric ion sequestering agents. 10. Selectivity of sulfonated poly(catechoylamides) for ferric ion
Kappel, M. J., & Raymond, K. N. (1982) · Inorganic Chemistry · doi:10.1021/ic00139a034 · Cited by 37
Gallium and Indium Complexes of Bis(amino thiol) (N2S2) Ligands
Zheng, Y. Y., Saluja, S., Yap, G. P. A., Blumenstein, M., Rheingold, A. L., & Francesconi, L. C. (1996) · Inorganic Chemistry · doi:10.1021/ic951535+ · Cited by 36
Chang, A. J., Sohn, R. E., Lu, Z. H., Arbeit, J. M., & Lapi, S. E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0058949 · Cited by 35
A highly effective bifunctional ligand for radioimmunotherapy applications
Chong, H., Song, H. A., Kang, C. S., Le, T., Sun, X. Y., Dadwal, M., Lee, H., Lan, X., Chen, Y., & Dai, A. (2011) · Chemical Communications · doi:10.1039/c0cc05707j · Cited by 34
Yong, K. J., Milenic, D. E., Baidoo, K. E., & Brechbiel, M. W. (2012) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2012.09.015 · Cited by 33
Park, G., Dadachova, E., Przyborowska, A. M., Lai, S.-J., Ma, D., Broker, G. A., Rogers, R. D., Planalp, R. P., & Brechbiel, M. W. (2001) · Polyhedron · doi:10.1016/s0277-5387(01)00927-5 · Cited by 33
Synthesis and Characterization of Two 111In-Labeled DTPA−Peptide Conjugates
Liu, S., & Edwards, D. S. (2001) · Bioconjugate Chemistry · doi:10.1021/bc010013h · Cited by 33
Radioimmunotherapy of non-Hodgkin’s lymphoma: a critical appraisal
Sharkey, R. M., Burton, J., & Goldenberg, D. M. (2005) · Expert Review of Clinical Immunology · doi:10.1586/1744666x.1.1.47 · Cited by 33
Eiblmaier, M., Andrews, R., Laforest, R. A., Rogers, B. E., & Anderson, C. J. (2007) · Journal of Nuclear Medicine · doi:10.2967/jnumed.107.039990 · Cited by 31
Максимилианович, Т. В., Wållberg, H., Andersson, K., Wennborg, A., Lundqvist, H., & Orlova, A. (2009) · European Journal of Nuclear Medicine and Molecular Imaging · doi:10.1007/s00259-009-1134-9 · Cited by 30
Garmestani, K., Yao, Z., Zhang, M., Wong, K. J., Park, C., Pastan, I. H., Carrasquillo, J. A., & Brechbiel, M. W. (2001) · Nuclear Medicine and Biology · doi:10.1016/s0969-8051(00)00203-1 · Cited by 30
Synthesis and Evaluation of Novel Polyaminocarboxylate-Based Antitumor Agents
Chong, H., Ma, X., Lee, H., Bui, P. M., Song, H. A., & Birch, N. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701307j · Cited by 28
Yong, K. J., Milenic, D. E., Baidoo, K. E., et al. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.189 · Cited by 28
Tatsi, A., Μάινα, Θ., Cescato, R., Waser, B., Krenning, E. P., de Jong, M., Cordopatis, P. A., Reubi, J. C., & Nock, B. A. (2012) · EJNMMI Research · doi:10.1186/2191-219x-2-25 · Cited by 25
Malmberg, J., Максимилианович, Т. В., & Orlova, A. (2011) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2011.217 · Cited by 23
Ferreirós‐Martínez, R., Esteban‐Gómez, D., Platas‐Iglesias, C., Blas, A. D., & Rodríguez-Blas, T. (2009) · Inorganic Chemistry · doi:10.1021/ic900838j · Cited by 23
Yapp, D. T. T., Ferreira, C. L., Gill, R. K., Boros, E., Wong, M. Q., Mandel, D., Jurek, P. E., & Kiefer, G. E. (2013) · Molecular Imaging · doi:10.2310/7290.2012.00044 · Cited by 17
Hohloch, K., Zinzani, P. L., Linkesch, W., Jurczak, W. J., Deptała, A., Lorsbach, M., Windemuth-Kiesselbach, C., Wulf, G. G., & Trümper, L. H. P. (2010) · Bone Marrow Transplantation · doi:10.1038/bmt.2010.202 · Cited by 10
Cited by
Inverse electron demand Diels–Alder reactions in chemical biology
Oliveira, B. L., Guo, Z., & Bernardes, G. J. L. (2017) · Chemical Society Reviews · doi:10.1039/c7cs00184c · Cited by 1,139
Long-Lived Emissive Probes for Time-Resolved Photoluminescence Bioimaging and Biosensing
Zhang, K. Y., Yu, Q., Wei, H., Liu, S., Zhao, Q., & Huang, W. (2018) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00425 · Cited by 923
ImmunoPET: Concept, Design, and Applications
Wei, W., Rosenkrans, Z. T., Liu, J., Huang, G., Luo, Q.-Y., & Cai, W. (2020) · Chemical Reviews · doi:10.1021/acs.chemrev.9b00738 · Cited by 484
Radioactive Main Group and Rare Earth Metals for Imaging and Therapy
Kostelnik, T. I., & Orvig, C. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00294 · Cited by 483
Self-citationClassification of Metal-Based Drugs according to Their Mechanisms of Action
Boros, E., Dyson, P. J., & Gasser, G. (2020) · Chem · doi:10.1016/j.chempr.2019.10.013 · Cited by 437
Metadata
- Authors
- Price, E. W., & Orvig, C.
- Venue
- Chem. Soc. Rev.
- Publisher
- Royal Society of Chemistry (RSC)
- Published
- 2014
- Volume
- 43
- Issue
- 1
- Pages
- 260-290
- ISSN
- 0306-0012 (ISSN-L)
- 1460-4744
- OpenAlex
- W1966335626
- Cited by
- 1,018
- References
- 166
- FWCI
- 6.83
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.